We are live on ! Find out more
WFM

Wilmington Funds Management Portfolio holdings

AUM $988M
1-Year Est. Return 26.05%
This Fund
S&P 500
This Quarter Est. Return
+4.48%
1 Year Est. Return
+26.05%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$988M
AUM Growth
+$67.7M
Cap. Flow
+$35.7M
Cap. Flow %
3.61%
Top 10 Hldgs %
10.81%
Holding
873
New
103
Increased
253
Reduced
220
Closed
127

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$6.38M
2
AGN
Allergan Inc
AGN
+$5.74M
3
OII icon
Oceaneering
OII
+$4.45M
4
FRX
FOREST LABORATORIES INC
FRX
+$3.94M
5
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
+$3.61M

Top Sells

Rank Stock Value
1
CTXS
Citrix Systems Inc
CTXS
+$5.03M
2
XOM icon
ExxonMobil
XOM
+$4.42M
3
GE icon
GE Aerospace
GE
+$3.28M
4
CVX icon
Chevron
CVX
+$2.84M
5
HLF icon
Herbalife
HLF
+$2.82M

Sector Composition

Rank Sector Weight
1 Industrials 15.33%
2 Consumer Discretionary 12.29%
3 Healthcare 11.76%
4 Technology 11.66%
5 Real Estate 9.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OREX
676
DELISTED
Orexigen Therapeutics, Inc.
OREX
$201K 0.02%
3,254
– –
CVEO icon
677
Civeo
CVEO
$376M
$200K 0.02%
+667
New +$200K
NWSA icon
678
News Corp Class A
NWSA
$15.3B
$200K 0.02%
11,157
– –
XRX icon
679
Xerox
XRX
$360M
$197K 0.02%
6,019
-6,717
-53% -$213K
SAPE
680
DELISTED
SAPIENT CORP
SAPE
$191K 0.02%
11,770
– –
EVC icon
681
Entravision Communication
EVC
$1.01B
$185K 0.02%
29,776
– –
RF icon
682
Regions Financial
RF
$26.7B
$184K 0.02%
17,356
-11,000
-39% -$115K
RUTH
683
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
$184K 0.02%
14,914
-6,600
-31% -$81.2K
FIX icon
684
Comfort Systems
FIX
$57.2B
$180K 0.02%
11,403
– –
OPK icon
685
Opko Health
OPK
$1.23B
$173K 0.02%
19,530
– –
JBLU icon
686
JetBlue
JBLU
$2.23B
$171K 0.02%
15,804
– –
ODP
687
DELISTED
ODP
ODP
$170K 0.02%
2,992
– –
AEO icon
688
American Eagle Outfitters
AEO
$3.04B
$167K 0.02%
+14,840
New +$169K
KEY icon
689
KeyCorp
KEY
$24.3B
$166K 0.02%
11,570
-8,500
-42% -$117K
CPSS icon
690
Consumer Portfolio Services
CPSS
$207M
$160K 0.02%
20,960
+2,216
+12% +$16.3K
PLCM
691
DELISTED
POLYCOM INC
PLCM
$160K 0.02%
+12,800
New +$162K
ARRY
692
DELISTED
Array Biopharma Inc
ARRY
$159K 0.02%
34,890
-6,290
-15% -$26K
SRI icon
693
Stoneridge
SRI
$208M
$158K 0.02%
14,776
– –
MDR
694
DELISTED
McDermott International
MDR
$147K 0.01%
+6,060
New +$133K
ENTG icon
695
Entegris
ENTG
$18B
$146K 0.01%
+10,650
New +$126K
BLT
696
DELISTED
BLOUNT INTERNATIONAL (NEW)
BLT
$142K 0.01%
10,039
– –
AMN icon
697
AMN Healthcare
AMN
$1.35B
$141K 0.01%
11,483
-2,230
-16% -$26.7K
DRH icon
698
Diamondrock Hospitality Co
DRH
$2.67B
$140K 0.01%
10,947
– –
GRT
699
DELISTED
GLIMCHER REALTY TRUST
GRT
$134K 0.01%
12,345
– –
ARIA
700
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$133K 0.01%
+20,940
New +$144K
26 27
28
29 30

Similar funds

SCM
Stux Capital Management New York $766M AUM 28.03% 1-Year Est. Return
MIU
Man Investments (UK) London, United Kingdom $1.29B AUM 31.85% 1-Year Est. Return
SR
Swiss Reinsurance Zurich, Switzerland $664M AUM 11.24% 1-Year Est. Return
CH
Cavalane Holdings Sydney, Australia $558M AUM
WTIM
Wilmington Trust Investment Management Wilmington, Delaware $492M AUM 25.19% 1-Year Est. Return
FOAM
Five Oceans Asset Management Sydney, Australia $438M AUM 24.83% 1-Year Est. Return
BII
Baring International Investment London, United Kingdom $1.57B AUM 24.97% 1-Year Est. Return
HGI
Hansberger Global Investors Ft Lauderdale, Florida $354M AUM 17.2% 1-Year Est. Return

Wilmington Funds Management's Q2 2014 Portfolio in Review

As of Q2 2014, Wilmington Funds Management held 873 positions worth $988M, up 7.4% from $920M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Wilmington Funds Management deployed $35.7M of net new capital in Q2 2014, opening 103 new positions and adding to 253 existing holdings. Its largest new stake was AstraZeneca: 88,300 shares worth $6.56M.

By sector, the portfolio is most concentrated in Industrials at 15% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Citrix Systems Inc, an estimated $5.03M trimmed.

  • Wilmington Funds Management's largest Q2 2014 buy was AstraZeneca: 88,300 shares worth $6.56M.
  • Wilmington Funds Management added most to Allergan Inc in Q2 2014, an estimated $5.74M increase.
  • Wilmington Funds Management's biggest Q2 2014 reduction was Citrix Systems Inc, cutting an estimated $5.03M.
  • Wilmington Funds Management fully exited Wolfspeed in Q2 2014, selling an estimated $1.9M.
  • Wilmington Funds Management's ten largest holdings make up 11% of its $988M portfolio in Q2 2014.
  • Wilmington Funds Management opened 103 new positions and closed 127 in Q2 2014.
  • Wilmington Funds Management's portfolio value rose 7.4% quarter-over-quarter to $988M.

Based on Wilmington Funds Management's 13F filing for Q2 2014, filed 13 Aug 2014.